Clinical Trial Update: PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial of PS-Omega3 supplementation in children with ADHD. The sponsor is Tel-Aviv Sourasky Medical Center…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• PS-Omega3 Supplementation (Omega-3 fatty acid supplementation)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: ADHD | Phase 2 | Status: UNKNOWN